George Adams MD Named CMO of Cordis

Globally recognized interventional cardiologist is the latest addition to a growing leadership team

George Adams, MD, MHS, MBA, FACC, FSCAI has been named Chief Medical Officer of Cordis, a global cardiovascular technology company, furthering the organization’s mission to differentiate itself as a technological leader and value-based global medical device company.

“We are delighted to have Dr. Adams join our team as we continue to build the new Cordis,” said CEO Shar Matin. “His depth of expertise in the treatment of both complex coronary and peripheral vascular disease will play a vital role in furthering our mission to improve patient care at pace with cost-effective, differentiated solutions that build on our legacy of innovation.”

Dr. Adams comes to Cordis with a distinguished combination of clinical practice, medical research, and product development experience. He is globally recognized for his expertise in the treatment of peripheral vascular disease in patients with critical limb ischemia (CLI) and treatment of coronary artery disease in patients with acute coronary syndromes. He is involved in the development of regional and national systems of care for the treatment of CLI, ST-Elevation Myocardial Infarction (STEMI), and management of complex coronary and peripheral vascular disease. He has a well-established network of peers and associates who are viewed as key opinion leaders within the global cardiovascular community.

Dr. Adams plays an integral role in global peer education. He strives to advance the field of medicine through leadership and moderation of, as well as participation in, numerous cardiovascular and peripheral vascular forums spanning national and global platforms.

He is a sought-after speaker and well-published researcher, serving as primary investigator for multiple clinical trials. He is certified by The American Board of Internal Medicine in internal medicine and cardiovascular disease.

“It is with great honor and excitement that I join the Cordis team as Chief Medical Officer,” said Dr. Adams.  “I look forward to playing a role in reinvigorating an incredible 62-year legacy.  I am grateful to be a part of the future that Cordis is building with integrity and a vision for innovation.”

Other Executives In the News

SourceCordis
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr A Burton Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.
John Taylor brings more than 30 years of regulatory experience to his role at ELIQUENT, including a distinguished 20-year career at the U.S. Food and Drug Administration (FDA), where he served in multiple leadership positions, including as FDA’s Acting Deputy Principal Commissioner, FDA Counselor to the Commissioner, Acting Deputy Commissioner for Global Regulatory Operations and Policy, and Associate Commissioner for Regulatory Affairs.
Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version